Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and […]

Zeist, The Netherlands – Scinus Group today announced the successful closing of a €3 million strategic investment round led by Myosotis Investments, founded by biotech entrepreneur Wietse Mulder. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in the round.The investment marks an important milestone in Scinus’ development and will support the accelerated commercial roll-out of the Osilaris™ […]

Appoints Frederik Decouttere as CEO LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million), led by Genku Ventures and joined by Novalis Biotech and Zürcher Kantonalbank as well as several […]

mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research Launch follows successful close of oversubscribed $15.5 million seed financing led by ARCH Venture Partners Gautam Kollu, former CCO of Grail, joins Board Syndex […]

STOCKHOLM, Sweden — CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and […]

TeraView, the pioneer and leader in terahertz technology and solutions, is the first UK and European-based company to list on KOSDAQ, the secondary Korean stock market for small to medium-sized (SME) high-growth, technology and venture companies. TeraView listed on December 9 and supports companies such as NVIDIA, AMD, Intel, Samsung, Ford, Volkswagen and other major […]

New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery LONDON — Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus […]

Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK: Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 […]

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validation Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins […]

HOLLYWOOD, Fla. — StarLIMS, a global enterprise informatics platform for laboratories, today announced a strategic investment by Turn/River Capital, a leading software private equity firm. Existing investor Francisco Partners will exit its investment as a result of this transaction. StarLIMS powers manufacturing and research lab operations worldwide. The company enables greater data automation and visibility, […]